stocksbrew

Why TNDM Stock Fell 0.1% on Nov 18, 2026

as of Wednesday, 9:53 AM ET

The reason we found

Stifel upgrades Tandem Diabetes Care to Buy

Stifel’s upgrade from Hold to Buy and higher price target of $26 provide a bullish reassessment of Tandem Diabetes Care’s prospects. The improved analyst view plausibly attracted buyers and helps explain the stock’s 3.22% gain today.

analyst upgradehigh confidence

Sources 1

Weekend

Still Sunday. Nothing's moving except the clock.

1days01hrs24min00sec

Market opens Monday, Nov 23 at 9:30 AM ET